Bio-Rad Labs (BIO) Issues Q3 EPS of $1.61, Beats by 8c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $380.03 +0.95%
Financial Fact:
Provision for income taxes: -8.85M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Provision for income taxes: -8.85M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q3 EPS of $1.61, $0.08 better than the analyst estimate of $1.53. Revenue for the quarter came in at $516.5 million versus the consensus estimate of $511.47 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
- Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
